Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Public Policy - April, 2004
28 articles
- Philippines Revamps Trademark Filing Rules
- Senate Committee OKs Bill To Raise USPTO Fees, End Fee Diversion
- European Copyright Ruling Could Prove Salient In Microsoft Antitrust Case
- EU Court Rejects Trademarks For 3D Shapes
- European Union Clears IP Enforcement Directive
- Israel, Under Pressure From Generics Industry, Delays Changes To Patent Law
- U.S. Justice Dept. Names Members Of Intellectual Property Task Force
- South Korea Protests Japan's Import Ban On Samsung Plasma Displays
- Advocacy Group Targets Business Method Patents For Re-Examination
- Israel Expected To OK 5-Year Drug Marketing Exclusivity
- Canada Strips Patent Holder Rights In Amended Drug Export Bill
- Russia Amends Copyright Law
- Industry Group To Counsel U.S. On Patent Reform
- E.U. Mulls Law To Regulate Royalties Collection
- National Research Council Urges Patent Reforms
- Shanghai To Open Intellectual Property Office Park
- U.S. To Put Israel On IP Priority Watch List, Newspaper Claims
- FTC Conference On Patent Reform Draws Top Decision Makers
- Indian Drug Companies Urge Government To Pass Data Exclusivity Law
- Poland To Seek Exemption From E.U. Data Protection Scheme
- U.S. Congress To Hear Testimony On Trademark Dilution Act
- E.U. Relaxes Antitrust Policing With New IP Licensing Rules
- Sandoz Lawsuit Vs. European Commission Highlights Uncertainties Over Biogenerics
- Greenpeace Blocks European Patent Office
- U.N., Clinton Foundation Expands Plan For Anti-HIV Generics
- FTC Backs Teva In Zoloft Patent Suit
- Israel To Make Concessions To U.S. On Pharma IPR
- U.S. Justice Department Sets Up IP Taskforce